BioCentury | Jul 31, 2020
Distillery Therapeutics

Oral small molecule viral RNA polymerase inhibitor for parainfluenza virus

...published online July 13, 2020 doi:10.1038/s41564-020-0752-7 CONTACT: Richard K. Plemper, Georgia State University, Atlanta, Ga. email: rplemper@gsu.edu Claire Quang Georgia State University Viral...
BioCentury | Sep 19, 2019
Translation in Brief

Public funding highlights

...million over five years to University of Connecticut , The Henry M. Jackson Foundation , Georgia State University...
BioCentury | Dec 6, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2018

...identified two iminooxazolidin-based inhibitors of Enterovirus 3C protease that could help treat Enterovirus 71 infection Georgia State University...
BioCentury | Nov 13, 2018
Distillery Therapeutics

Infectious disease

...Wang, Georgia State University, Atlanta, Ga. email: wang@gsu.edu CONTACT: Luqing Shang, Nankai University, Tianjin, China email: shanglq@nankai.edu.cn Claire Quang Georgia State University Nankai...
BioCentury | Feb 6, 2018
Distillery Therapeutics

Infectious disease

...published online Jan. 24, 2018 doi:10.1038/s41467-017-02725-4 CONTACT: Bao-Zhong Wang, Georgia State University, Atlanta, Ga. email: bwang23@gsu.edu Hongjiang Li Georgia State University Influenza...
BioCentury | Jan 27, 2017
Company News

GeoVax, Georgia State deal

...time for publication. GeoVax Labs Inc. (OTCBB:GOVX), Atlanta, Ga. Georgia State University , Atlanta, Ga. Business: Infectious Chris Lieu Georgia State University GeoVax...
BioCentury | Jul 25, 2016
Company News

Georgia State University, Aviragen deal

...virus (RSV) replication inhibitors discovered by the university. The partners did not respond to inquiries. Georgia State University...
BioCentury | Jun 23, 2016
Distillery Therapeutics

Therapeutics: Integrin avβ3 (CD51/CD61)

...Turaga, R. et al. Nat. Commun.; published online May 31, 2016 doi:10.1038/ncomms11675 CONTACT: Zhi-Ren Liu, Georgia State University...
BioCentury | Mar 2, 2015
Company News

Georgia State University, Cisen Pharmaceutical deal

...for milestones and royalties but declined to provide details. Cisen did not respond to inquiries. Georgia State University...
BioCentury | Dec 11, 2014
Distillery Therapeutics

Indication: Infectious disease

...licensing Zhang, B. et al. Science; published online Nov. 14, 2014; doi:10.1126/science.1256999 Contact: Benyue Zhang, Georgia State University...
Items per page:
1 - 10 of 18
BioCentury | Jul 31, 2020
Distillery Therapeutics

Oral small molecule viral RNA polymerase inhibitor for parainfluenza virus

...published online July 13, 2020 doi:10.1038/s41564-020-0752-7 CONTACT: Richard K. Plemper, Georgia State University, Atlanta, Ga. email: rplemper@gsu.edu Claire Quang Georgia State University Viral...
BioCentury | Sep 19, 2019
Translation in Brief

Public funding highlights

...million over five years to University of Connecticut , The Henry M. Jackson Foundation , Georgia State University...
BioCentury | Dec 6, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2018

...identified two iminooxazolidin-based inhibitors of Enterovirus 3C protease that could help treat Enterovirus 71 infection Georgia State University...
BioCentury | Nov 13, 2018
Distillery Therapeutics

Infectious disease

...Wang, Georgia State University, Atlanta, Ga. email: wang@gsu.edu CONTACT: Luqing Shang, Nankai University, Tianjin, China email: shanglq@nankai.edu.cn Claire Quang Georgia State University Nankai...
BioCentury | Feb 6, 2018
Distillery Therapeutics

Infectious disease

...published online Jan. 24, 2018 doi:10.1038/s41467-017-02725-4 CONTACT: Bao-Zhong Wang, Georgia State University, Atlanta, Ga. email: bwang23@gsu.edu Hongjiang Li Georgia State University Influenza...
BioCentury | Jan 27, 2017
Company News

GeoVax, Georgia State deal

...time for publication. GeoVax Labs Inc. (OTCBB:GOVX), Atlanta, Ga. Georgia State University , Atlanta, Ga. Business: Infectious Chris Lieu Georgia State University GeoVax...
BioCentury | Jul 25, 2016
Company News

Georgia State University, Aviragen deal

...virus (RSV) replication inhibitors discovered by the university. The partners did not respond to inquiries. Georgia State University...
BioCentury | Jun 23, 2016
Distillery Therapeutics

Therapeutics: Integrin avβ3 (CD51/CD61)

...Turaga, R. et al. Nat. Commun.; published online May 31, 2016 doi:10.1038/ncomms11675 CONTACT: Zhi-Ren Liu, Georgia State University...
BioCentury | Mar 2, 2015
Company News

Georgia State University, Cisen Pharmaceutical deal

...for milestones and royalties but declined to provide details. Cisen did not respond to inquiries. Georgia State University...
BioCentury | Dec 11, 2014
Distillery Therapeutics

Indication: Infectious disease

...licensing Zhang, B. et al. Science; published online Nov. 14, 2014; doi:10.1126/science.1256999 Contact: Benyue Zhang, Georgia State University...
Items per page:
1 - 10 of 18